1248.7.01013 Boehringer Ingelheim Investigational Site
Philadelphia, Pennsylvania
0 studies enrolling now · 1 studies all time
What they study most
Asthma
Studies at this site
Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).
— Stopped early